To include your compound in the COVID-19 Resource Center, submit it here.

XEN-D0103: Phase II started

Xention began the double-blind, placebo-controlled, crossover, U.K. Phase II XAPAF trial to

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE